PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0009782|connective tissue disease |
| Sentences | 10 |
| PubMedID- 25026800 | Aim: to evaluate the short-term efficacy of the nonselective endothelin receptor antagonist bosentan in the treatment of pulmonary hypertension (ph) associated with diffuse connective tissue diseases (ctd), as well as its effect on survival in both monotherapy and in combination with other ph-specific agents. |
| PubMedID- 23732415 | [pulmonary hypertension associated with connective tissue diseases]. |
| PubMedID- 23154245 | Furthermore, we emphasize that cardiac catheterization played a critical role in the differential diagnosis from pulmonary hypertension associated with connective tissue disease. |
| PubMedID- 21165350 | Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease. |
| PubMedID- 22872790 | The pivotal subcutaneous treprostinil trial by simmoneau et al in 2002 enrolled 470 patients at 24 us centers and 16 international sites with pah, either primary pulmonary hypertension, that associated with connective tissue disease or congenital systemic-to-pulmonary shunts in a 12-week, double-blind, placebo-controlled trial. |
| PubMedID- 21918364 | A histopathological study of pulmonary hypertension in connective tissue disease. |
| PubMedID- 22884388 | The importance of pvod as the basis of pulmonary hypertension in patients with connective tissue disease has been recently proposed, as well as the role of thrombogenesis, in the development of pvod. |
| PubMedID- 24400542 | pulmonary hypertension associated with connective tissue diseases]. |
| PubMedID- 25736353 | Left heart abnormalities in connective tissue disease patients with pre-capillary pulmonary hypertension as well as borderline mean pulmonary arterial pressure. |
| PubMedID- 21211937 | Pulmonary veno-occlusive disease: the bete noire of pulmonary hypertension in connective tissue diseases. |
Page: 1